These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32924684)

  • 1. Associated factors of early-onset pulmonary hypertension and clinical difference between early- and late-onset pulmonary hypertension in Thai systemic sclerosis.
    Krikeerati T; Pussadhamma B; Mahakkanukrauh A; Suwannaroj S; Nanagara R; Foocharoen C
    Mod Rheumatol; 2021 May; 31(3):649-656. PubMed ID: 32924684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, predictors, and survival of pulmonary hypertension determined by echocardiography in Thai patients with early systemic sclerosis (SSc): inception cohort study.
    Wangkaew S; Pota P; Prasertwittayakij N; Phrommintikul A
    Clin Rheumatol; 2021 Mar; 40(3):973-980. PubMed ID: 32683661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of pulmonary hypertension in patients with systemic sclerosis and no pulmonary symptoms: is annual echocardiographic screening necessary?
    Foocharoen C; Mahakkanukrauh A; Pussadhamma B; Netwijitpan S; Suwannaroj S; Nanagara R
    J Clin Rheumatol; 2014 Aug; 20(5):268-74. PubMed ID: 25036561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is pulmonary arterial hypertension really a late complication of systemic sclerosis?
    Hachulla E; Launay D; Mouthon L; Sitbon O; Berezne A; Guillevin L; Hatron PY; Simonneau G; Clerson P; Humbert M;
    Chest; 2009 Nov; 136(5):1211-1219. PubMed ID: 19429720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-age onset systemic sclerosis.
    Manno RL; Wigley FM; Gelber AC; Hummers LK
    J Rheumatol; 2011 Jul; 38(7):1317-25. PubMed ID: 21685299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France.
    Hachulla E; de Groote P; Gressin V; Sibilia J; Diot E; Carpentier P; Mouthon L; Hatron PY; Jego P; Allanore Y; Tiev KP; Agard C; Cosnes A; Cirstea D; Constans J; Farge D; Viallard JF; Harle JR; Patat F; Imbert B; Kahan A; Cabane J; Clerson P; Guillevin L; Humbert M;
    Arthritis Rheum; 2009 Jun; 60(6):1831-9. PubMed ID: 19479881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment for Pulmonary Artery Hypertension Using Clinical and Echocardiographic Criteria in Patients With Systemic Sclerosis.
    Methia N; Latreche S; Ait Mokhtar O; Monsuez JJ; Benkhedda S
    Am J Med Sci; 2016 Oct; 352(4):343-347. PubMed ID: 27776714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.
    Argula RG; Karwa A; Lauer A; Gregg D; Silver RM; Feghali-Bostwick C; Schanpp LM; Egbert K; Usher BW; Ramakrishnan V; Hassoun PM; Strange C
    Ann Am Thorac Soc; 2017 May; 14(5):682-689. PubMed ID: 28282243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors for left ventricular diastolic dysfunction in a scleroderma cohort.
    Vemulapalli S; Cohen L; Hsu V
    Scand J Rheumatol; 2017 Jul; 46(4):281-287. PubMed ID: 27635465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and predictors of pulmonary artery hypertension in systemic sclerosis.
    Kumar U; Ramteke R; Yadav R; Ramam M; Handa R; Kumar A
    J Assoc Physicians India; 2008 Jun; 56():413-7. PubMed ID: 18822619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
    Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand.
    Foocharoen C; Nanagara R; Kiatchoosakun S; Suwannaroj S; Mahakkanukrauh A
    Int J Rheum Dis; 2011 Aug; 14(3):282-9. PubMed ID: 21816025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary arterial hypertension and systemic sclerosis relation: a single centre experience.
    Demir N; Şahin A; Küçükşahin O; Kayacan O; Dinçer İ; Sayın T; Karnak D; Turgay M
    Heart Lung Circ; 2014 Jul; 23(7):667-73. PubMed ID: 24613044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systemic sclerosis associated pulmonary arterial hypertension: the pitfalls].
    Hachulla E; Launay D; Le Pavec J; Mouthon L; Guillevin L; de Groote P
    Presse Med; 2011 Apr; 40 Suppl 1():1S46-53. PubMed ID: 21536180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the Singapore systemic sclerosis cohort.
    Noviani M; Saffari SE; Tan JL; Yip JWL; Teng GG; Law WG; Chan GYL; Santosa A; Lim AYN; Hong C; Ng SA; Tay ELW; Ruan W; Yap J; Low AHL
    Semin Arthritis Rheum; 2020 Jun; 50(3):473-479. PubMed ID: 31810742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in clinical presentation and incidence of cardiopulmonary involvement in late-onset versus early-onset systemic sclerosis: inception cohort study.
    Wangkaew S; Phiriyakrit P; Sawangduan V; Prasertwittayakij N; Euathrongchit J
    Int J Rheum Dis; 2018 May; 21(5):1082-1092. PubMed ID: 29673120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary hypertension in systemic sclerosis: diagnosis by systematic screening and prognosis after three years follow-up.
    Vilela VS; Dias MM; Salgado ÂA; da Silva BRA; Lopes AJ; Bessa EJC; Bruno LP; da Costa CH; Levy RA; Rufino R
    BMC Pulm Med; 2021 Jul; 21(1):251. PubMed ID: 34325685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.
    Volkmann ER; Saggar R; Khanna D; Torres B; Flora A; Yoder L; Clements PJ; Elashoff RM; Ross DJ; Agrawal H; Borazan N; Furst DE; Saggar R
    Arthritis Rheumatol; 2014 Jul; 66(7):1900-8. PubMed ID: 24729406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary arterial hypertension in Thai patients with systemic sclerosis.
    Wangkaew S; Kasitanon N; Phrommintikul A; Sukitawut W; Wichainun R; Louthrenoo W
    J Med Assoc Thai; 2008 Feb; 91(2):166-72. PubMed ID: 18389980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.